Wed, September 5, 2012
Tue, September 4, 2012
Mon, September 3, 2012
Sun, September 2, 2012
Sat, September 1, 2012
Fri, August 31, 2012
Thu, August 30, 2012
Wed, August 29, 2012
Tue, August 28, 2012
Mon, August 27, 2012
Sun, August 26, 2012
Sat, August 25, 2012
Fri, August 24, 2012
Thu, August 23, 2012
Wed, August 22, 2012
[ Wed, Aug 22nd 2012 ] - Market Wire
Inergetics Shareholder Update
Tue, August 21, 2012

Synta to Present at the Stifel Nicolaus Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. t-the-stifel-nicolaus-healthcare-conference.html
Published in Health and Fitness on Wednesday, August 29th 2012 at 6:20 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the Stifel Nicolaus Healthcare Conference on Wednesday, September 5 at 9:10 a.m. (ET) in Boston.

A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].


Publication Contributing Sources